Impact of tigecycline versus imipenem–cilastatin on fibrinogen levels following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study-Reference-Cited by-同舟云学术

Impact of tigecycline versus imipenem–cilastatin on fibrinogen levels following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study

Published:2018-03-22 Issue:4 Volume:30 Page:224-232
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Hakeam Hakeam A.¹²,Al Duhailib Zainab³,Salahuddin Nawal³^ORCID,Amin Tarek⁴

Affiliation:

1. Pharmaceutical Care Division, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

2. College of Medicine, Alfaisal University, Riyadh, Saudi Arabia

3. Critical Care Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

4. King Faisal Oncology Center, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2018.1452333

Reference34 articles.

1. Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer

2. Peritonectomy Procedures

3. Infectious Complications after Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy

4. Morbidity and Mortality Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy at a Single Institution in Japan

5. Complications and Toxicities After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety profiles of tetracycline-class drugs: a pharmacovigilance analysis of the FAERS database;Expert Opinion on Drug Safety;2024-09-04

2. Development and internal validation of a model for predicting cefoperazone/sulbactam-associated coagulation disorders in Chinese inpatients;BMC Pharmacology and Toxicology;2024-07-12

3. Changes in Coagulation in Cancer Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Treatment (HIPEC)—A Systematic Review;Seminars in Thrombosis and Hemostasis;2023-02-24

4. Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China;Frontiers in Pharmacology;2022-10-11

5. Risk factors of tigecycline-associated fibrinogen reduction in patients with renal transplantation: a case-control study;Translational Andrology and Urology;2022-10